Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yashaswini Kelagere"'
Autor:
Nicole Hardy, Charan Thej Reddy Vegivinti, Mansi Mehta, Jade Thurnham, Alexander Mebane, John M. Pederson, Ranita Tarchand, Jeevan Shivakumar, Peace Olaniran, Ritika Gadodia, Arup Ganguly, Yashaswini Kelagere, Rashmika Reddy Nallabolu, Mrunanjali Gaddam, Praneeth R. Keesari, Yashwitha Sai Pulakurthi, Rohit Reddy, Kevin Kallmes, Tejo N. Musunuru
Publikováno v:
Clinical and Experimental Medicine.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10e0420f5c0c67a75fd808bf6ca13dbe
https://doi.org/10.1007/s10238-023-01004-5
https://doi.org/10.1007/s10238-023-01004-5
Autor:
Mohan Pammi, Yashaswini Kelagere, Sara Koh, Amy Sisson, Joseph Hagan, Joshua Kailin, Caraciolo J Fernandes
Publikováno v:
Archives of Disease in Childhood - Fetal and Neonatal Edition. :fetalneonatal-2022
BackgroundPrognostication of mortality and decision to offer extracorporeal membrane oxygenation (ECMO) treatment in infants with congenital diaphragmatic hernia (CDH) can inform clinical management.ObjectiveTo summarise the prognostic value of echoc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb6943350e38a52ad9ed452b9ef4a27c
https://doi.org/10.1136/archdischild-2022-325257
https://doi.org/10.1136/archdischild-2022-325257
Publikováno v:
Methods Mol Biol
Methods in Molecular Biology ISBN: 9781071621271
Methods in Molecular Biology ISBN: 9781071621271
Although non-alcoholic steatohepatitis (NASH) can progress to liver cancer and liver failure, no FDA-approved drugs exist to treat NASH. Deciphering the molecular mechanisms underlying the pathogenesis of NASH will facilitate the development of effec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82cef2c41a8914f74f5d42a9e3721eb3
https://europepmc.org/articles/PMC9582736/
https://europepmc.org/articles/PMC9582736/
Autor:
Liu Y; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Division of Endocrinology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Xu S; Division of Endocrinology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.; Division of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Branch of the National Clinical Research Center for Metabolic Disease, Wuhan, China., Liu Y; Division of Endocrinology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.; Key Laboratory of Molecular Target & Clinical Pharmacology and the State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences & the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China., Gowda YKM; Sapthagiri Institute of Medical Sciences and Research Centre, Bangalore, India., Miao J; Division of Endocrinology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA. ji.miao@childrens.harvard.edu.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2022; Vol. 2455, pp. 343-358.